Lawmakers say the landmark price transparency law passed in 2016 is not getting the results they sought.
The State denies subsidized health insurance to a woman because her husband’s work offers a health plan. However, the husband is not enrolled in the plan because as a former foster child, he is covered under Medicaid until age 26. The wife appeals.
He called his plan to set aside $10 million of the projected cost “a different way of accounting” that gives the state flexibility.
The deal will pay OneCare Vermont, an accountable care organization, monthly fees to take care of 30,000 Medicaid patients this year rather than reimbursing for individual procedures.
He would put $10 million of the expected cost of the program into a reserve fund rather than incorporating it into the budget. Lawmakers say that threatens to undermine the forecasting process.
The reduction is said to be due in part to an effort to confirm eligibility based on income.
More than 50 percent of Planned Parenthood patients in Vermont have Medicaid for health insurance, the organization says.
He warned lawmakers and the governor about the possible conversion of Medicaid funding to block grants and said that could devastate community hospitals.
News Release — American Cancer Society Cancer Action Network Jan. 11, 2017 Contact: Amber Herting American Cancer Society Cancer Action Network Phone: 508-450-8690 E-mail: [email protected] Governor: Low-Income Cancer Patients and Survivors Need Continued Access to Meaningful Health Insurance Alternative Medicaid Financing Proposals Could Have Damaging Impact for Cancer Patients and Survivors Who Depend on the […]
The lengthy investigation still has one issue unresolved and will conclude “as soon and as efficiently as possible,” an official said. A former Retreat employee alleged Medicaid fraud.
Medicaid spending will once again be a driving factor in a projected $55 million to $75 million budget gap.
A new analysis recommends sticking with the existing health insurance exchange even though it has “significant deficiencies.”
The Department of Vermont Health Access, which administers Medicaid, will need to decide whether to go along. The drugs are widely considered some of the most expensive on the market.
The state should refund millions it received based on the assumption that every Vermonter would use the exchange, according to an inspector general’s report. The state says federal officials accepted that assumption.